We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
-1.15%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$253M
AUM Growth
+$222K
(+0.09%)
Cap. Flow
+$5.53M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
38.67%
Holding
59
New
2
Increased
15
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$1.34M |
| 2 |
Gilead Sciences
GILD
|
+$1.23M |
| 3 |
Biogen
BIIB
|
+$1.1M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$198K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$166K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.2% |
| 2 | Industrials | 20.01% |
| 3 | Technology | 17.15% |
| 4 | Communication Services | 9% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Broadcom
AVGO
$1.8T
| $4.32M | 1.7% |
183,350
+5,950
| +3% | +$150K |
|
|
RTN
27
DELISTED
Raytheon Company
RTN
| $4.32M | 1.7% |
20,000
| – | – |
|
28
Home Depot
HD
$334B
| $4.28M | 1.69% |
24,000
| – | – |
|
29
Pfizer
PFE
$142B
| $4.23M | 1.67% |
125,685
| – | – |
|
30
Merck
MRK
$313B
| $4.11M | 1.62% |
79,098
| – | – |
|
31
Illumina
ILMN
$28.4B
| $3.74M | 1.47% |
16,242
+668
| +4% | +$153K |
|
32
Colgate-Palmolive
CL
$73.4B
| $3.67M | 1.45% |
51,200
| – | – |
|
33
Stryker
SYK
$122B
| $3.08M | 1.22% |
19,145
+900
| +5% | +$145K |
|
34
Lowe's Companies
LOW
$115B
| $3.04M | 1.2% |
34,600
| – | – |
|
35
CSX Corp
CSX
$94B
| $3.01M | 1.19% |
162,000
| – | – |
|
36
CVS Health
CVS
$138B
| $2.97M | 1.17% |
47,705
| – | – |
|
37
Walmart Inc
WMT
$907B
| $2.94M | 1.16% |
99,000
| – | – |
|
38
AT&T
T
$151B
| $2.86M | 1.13% |
106,199
| – | – |
|
|
WBA
39
DELISTED
Walgreens Boots Alliance
WBA
| $2.68M | 1.06% |
40,900
| – | – |
|
40
Comcast
CMCSA
$84.2B
| $2.67M | 1.05% |
78,000
| – | – |
|
41
Perrigo
PRGO
$1.45B
| $2.63M | 1.04% |
31,565
+1,250
| +4% | +$109K |
|
|
42
Alphabet (Google) Class C
GOOG
$4.37T
| $2.33M | 0.92% |
45,120
| – | – |
|
43
PepsiCo
PEP
$187B
| $2.29M | 0.9% |
21,000
| – | – |
|
44
Zoetis
ZTS
$31.7B
| $2.07M | 0.82% |
24,818
| – | – |
|
45
Adobe
ADBE
$90.8B
| $1.95M | 0.77% |
9,000
| – | – |
|
|
ESRX
46
DELISTED
Express Scripts Holding Company
ESRX
| $1.66M | 0.65% |
24,000
| – | – |
|
47
DuPont de Nemours
DD
$18.5B
| $1.63M | 0.64% |
10,125
| – | – |
|
48
Bristol-Myers Squibb
BMY
$125B
| $1.47M | 0.58% |
23,200
| – | – |
|
49
International Flavors & Fragrances
IFF
$19.8B
| $1.37M | 0.54% |
10,000
| – | – |
|
|
50
Gilead Sciences
GILD
$167B
| $1.17M | 0.46% |
+15,500
| New | +$1.23M |
|
Similar funds
RC
TTSTC
KFAS
KGAMU
RIS
AMG
BWP
MC
Chad R. Baker's Q1 2018 Portfolio in Review
As of Q1 2018, Chad R. Baker held 59 positions worth $253M, up 0.09% from $253M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.4%. Chad R. Baker opened 2 new positions and made no exits, leaving the 59-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.
- Chad R. Baker's largest Q1 2018 buy was Gilead Sciences: 15,500 shares worth $1.17M.
- Chad R. Baker added most to Analog Devices in Q1 2018, an estimated $1.34M increase.
- Chad R. Baker's ten largest holdings make up 39% of its $253M portfolio in Q1 2018.
- Chad R. Baker opened 2 new positions and closed 0 in Q1 2018.
- Chad R. Baker's portfolio value rose 0.09% quarter-over-quarter to $253M.
Based on Chad R. Baker's 13F filing for Q1 2018, filed 14 May 2018.